Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-09-22
1996-06-04
Fleisher, Mindy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514152, 514192, 424114, 530319, 530350, 536 136, 536 168, A61K 3817, C07G 1100, C07H 15234, C07K 1447
Patent
active
055232884
ABSTRACT:
The present invention relates to methods and compositions for treating gram-negative bacterial infections, using BPI protein products. Co-treatment, or concurrent administration, of BPI protein product with an antibiotic in treatment of gram-negative bacterial infections improves the therapeutic effectiveness of the antibiotic, including increasing antibiotic susceptibility of gram-negative bacteria and reversing resistance of the bacteria to antibiotics.
REFERENCES:
patent: 4863727 (1989-08-01), Zimmerman et al.
patent: 5000958 (1991-03-01), Fountain et al.
patent: 5089274 (1992-02-01), Marra et al.
patent: 5156665 (1992-10-01), Sherba et al.
patent: 5171739 (1992-12-01), Scott
patent: 5198541 (1993-03-01), Elsbach et al.
patent: 5234912 (1993-08-01), Marra et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5334584 (1994-08-01), Scott et al.
patent: 5348942 (1994-09-01), Little, II et al.
Davies, "Inactivation of Antibiotics and the Dissemination of Resistance Genes", Science, 264:375-381 (Apr. 15, 1994).
Eliopoulos and Moellering, "Antimicrobial Combinations", in Antibiotics in Laboratory Medicine, 3rd ed., pp. 432-492, (Lorian ed., Baltimore, MD) (1991).
Elsbach, "Antibiotics from Within: Antibacterials from Human and Animal Sources", Trends. Biotech., 8(1):26-30 (Jan. 1990).
Elsbach and Weiss, "Oxygen-Independent Bactericidal Systems of Polymorphonuclear Leukocytes", in Advances in Inflammation Research, vol. 2, pp. 95-113 (Weissmann ed., Raven Press, Ltd.) (1981).
Elsbach and Weiss, "Oxygen-Independent Antimicrobial Systems of Phagocytes," in Inflammation: Basic Principles and Clincial Correlates, pp. 603-636, (Gallin et al. eds., Raven Press, Ltd.) (1992).
Elsbach et al., "Separation and Purification of a Potent Bactericidal/Permeability-Increasing Protein and a Closely Associated Phospholipase A.sub.2 from Rabbit Polymorphonuclear Leukocytes", J. Biol. Chem., 254(21):11000-11009 (Nov. 10, 1979).
Gabay, "Ubiquitous Natural Antibiotics", Science, 264:373-374 (Apr. 15, 1994).
Gazzano-Santoro et al., "High-Affinity Binding of the Bactericidal/Permeability-Increasing Protein and a Recombinant Amino-Terminal Fragment to the Lipid A Region of Lipopolysaccharide", Infect. Immun., 60(11):4754-4761 (Nov. 1992).
Gray et al., "Cloning of the cDNA of a Human Neutrophil Bactericidal Protein", J. Biol. Chem., 264(16):9505-9509 (Jun. 5, 1989).
Kadurugamuwa et al., "Interaction of Gentamicin with the A Band and B Band Lipopolysaccharides of Pseudomonas aeruginosa and Its Possible Lethal Effect", Antimicrobial Agents and Chemotherapy, 37(4):715-721 (Apr. 1993).
Kingman, "Resistance a European Problem, Too", Science, 264:363-365 (Apr. 15, 1994).
Levy et al., "Antibacterial 15-kDa Protein Isoforms (p15s) are Members of a Novel Family of Leukocyte Proteins", J. Biol. Chem., 268(8):6058-6068 (Mar. 16, 1993).
Mannion et al., "Preferential Binding of the Neutrophil Cytoplasmic Granule-Derived Bactericidal/Permeability Increasing Protein to Target Bacteria", J. Clin. Invest., 142(8):2807-2812 (Apr. 15, 1989).
Mannion et al., "Separation of Sublethal and Lethal Effects of Polymorphonuclear Leukocytes on Escherichia coli", J. Clin. Invest., 86:631-641 (Aug. 1990).
Mannion et al., "Separation of Sublethal and Lethal Effects of the Bactericidal/Permeability Increasing Protein on Escherichia coli", J. Clin. Invest., 85:853-860 (Mar. 1990).
Nikaido, "Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux", Science, 264:382-387 (Apr. 15, 1994).
Ooi et al., "A 25-kDa NH.sub.2 -terminal Fragment Carries All the Antibacterial Activities of the Human Neutrophil 60-kDa Bactericidal/Permeability-Increasing Protein", J. Biol. Chem., 262(31):14891-14894 (1987).
Ooi et al., "Endotoxin-neutralizing Properties of the 25 kD N-Terminal Fragment and a Newly Isolated 30 kD C-Terminal Fragment of the 55-60 kD Bactericidal/Permeability-Increasing Protein of Human Neutrophils", J. Exp. Med., 174:649-655 (Sep. 1991).
Ooi et al., "Isolation of Two Isoforms of a Novel 15-kDa Protein from Rabit Polymorphonuclear Leukocytes that Modulate the Antibacterial Actions of Other Leukocyte Proteins", J. Biol. Chem., 265(26):15956-15962 (Sep. 15, 1990).
Spratt, "Resistance to Antibiotics Mediated by Target Alterations", Science, 264:388-393 (Apr. 15, 1994).
Stratton, "In Vitro Testing: Correlations Between Bacterial Susceptibility, Body Fluid Levels and Effectiveness of Antibacterial Therapy", in Antibiotics in Laboratory Medicine, pp. 849-879 (Lorian ed., Williams & Wilkins) (1991).
Taber et al., "Bacterial Uptake of Aminoglycoside Antibiotics", Microbiological Reviews, 51(4):439-457 (Dec. 1987).
Travis, "Reviving the Antibiotic Miracle", Science, 264:360-362 (Apr. 15, 1994).
Vaara, "Agents that Increase the Permeability of the Outer Membrane", Microbiological Reviews, 56(3):395-411 (Sep. 1992).
Veld et al., "Effects of the Bactericidal/Permeability-Increasing Protein of Polymorphonuclear Leukocytes on Isolated Bacterial Cytoplasmic Membrane Vesicles", Infect. Immun., 56(5):1203-1208 (May 1988).
Weiss and Olsson, "Cellular and Subcellular Localization of the Bactericidal/Permeability-Increasing Protein of Neutrophils", Blood, 69(2):652-659 (Feb. 1987).
Weiss et al., "Human Bactericidal/Permeability-Increasing Protein and a Recombinant NH.sub.2 -Terminal Fragment Cause Killing of Serum-resistant Gram-negative Bacteria in Whole Blood and Inhibit Tumor Necrosis Factor Release Induced by the Bacteria", J. Clin. Invest., 90:1122-1130 (Sep. 1992).
Weiss et al., "Resistance of Gram-negative Bacteria to Purified Bactericidal Leukocyte Proteins", J. Clin. Invest., 65:619-628 (Mar. 1980).
Weiss et al., "The Role of Lipopolysaccharides in the Action of the Bactericidal/Permeability-Increasing Neutrophil Protein on the Bacterial Envelope", J. Immunol., 132(6):3109-3115 (Jun. 1984).
Cross et al. "Choice of Bacteria in Animal Models of Sepsis" Infection & Immunity 61(7):2741-2747 1993.
Dictionary of Drugs 1990 pp. 900, 886, 282.
Cohen Jonathan
Kung Ada H. C.
Lambert, Jr. Lewis H.
Little, II Roger G.
Degen Nancy J.
Fleisher Mindy
Xoma Corporation
LandOfFree
Method of treating gram-negative bacterial infection by administ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating gram-negative bacterial infection by administ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating gram-negative bacterial infection by administ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-383376